- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Intermediate and High-risk Luminal and Triple Negative Breast Cancer in Spain
Total 142 results
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
Hospital General Universitario Gregorio MarañonTerminatedTriple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female PatientsSpain
-
Fundacio Clinic BarcelonaSOLTI Breast Cancer Research GroupNot yet recruitingMetastatic Triple-Negative Breast CarcinomaSpain
-
Clinica Universidad de Navarra, Universidad de...Unknown
-
Vall d'Hebron Institute of OncologyRecruitingTriple Negative Breast CancerSpain
-
Fundacion OncosurPfizer; Apices Soluciones S.L.; Pierre Fabre Ibérica, S.A.CompletedTriple Negative Breast CancerSpain
-
SOLTI Breast Cancer Research GroupRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-negative Breast CancerSpain
-
Miguel Martín JiménezUNC Lineberger Comprehensive Cancer Center; Hospital Universitario Ramon y... and other collaboratorsActive, not recruitingBreast Cancer | Breast Cancer Stage II-IIISpain
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
PIQUR Therapeutics AGHospital Universitari Vall d'Hebron Research Institute; Institut Català d'Oncologia and other collaboratorsCompletedMetastatic Breast CancerSpain, United Kingdom
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
MedSIRGilead SciencesActive, not recruitingBreast Cancer | Triple Negative Breast CancerSpain
-
Hoffmann-La RocheActive, not recruitingTriple-Negative Breast CancerItaly, Portugal, Slovenia, Spain, Romania, France, Czechia, Peru, Argentina, Chile, Hungary, Mexico, Poland
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
SanofiTerminatedTriple Negative Breast CancerSpain, Belgium, Italy, Czechia, Netherlands
-
MedSIRHoffmann-La RocheCompletedTriple Negative Breast CancerSpain, Portugal
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
ERYtech PharmaTerminatedTriple Negative Breast CancerSpain, Belgium, Hungary
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Hoffmann-La RocheCompletedBreast CancerFrance, United States, Spain, United Kingdom, Australia
-
Cantargia ABSpanish Breast Cancer Research GroupRecruitingTriple Negative Breast CancerSpain
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
SanofiCompletedBreast Cancer, MetastaticAustralia, Belgium, France, Italy, Netherlands, Spain
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
SanofiSOLTI Breast Cancer Research GroupCompletedBreast Cancer FemaleSpain, France, Germany
-
Zenith EpigeneticsPfizer; Newsoara Biopharma Co., Ltd.TerminatedTriple Negative Breast CancerUnited States, Belgium, China, Spain
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
German Breast GroupGilead Sciences; ETOP IBCSG Partners Foundation; UNICANCER; Austrian Breast & Colorectal... and other collaboratorsRecruitingTriple Negative Breast Cancer | HER2-negative Breast CancerSpain, France, Germany, Austria, Belgium, Ireland, Italy, Switzerland
-
Genentech, Inc.SOLTI Breast Cancer Research GroupCompletedBreast CancerUnited States, Spain, Portugal
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Italy, France
-
Dompé Farmaceutici S.p.APRA Health SciencesCompletedMetastatic Breast CancerUnited States, Spain, Belgium, Italy, France, Czechia, Poland
-
PfizerCompletedNeoplasmUnited States, Spain, Canada, Italy, United Kingdom
-
Genentech, Inc.Hoffmann-La RocheCompletedBreast CancerUnited States, Belgium, France, Germany, United Kingdom, Spain
-
Hoffmann-La RocheTerminatedBreast CancerIsrael, Italy, Spain, United States, Belgium, Czechia, Australia, United Kingdom, Korea, Republic of, Romania, France, Taiwan, Latvia
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
BerGenBio ASAMerck Sharp & Dohme LLCTerminatedTriple Negative Breast Cancer | Inflammatory Breast Cancer Stage IVSpain, United States, United Kingdom, Norway
-
Hoffmann-La RocheRecruitingBreast CancerKorea, Republic of, United States, Israel, Denmark, Argentina, Mexico, Brazil, Germany, Peru, Poland, Spain, Taiwan, South Africa, Czechia, Italy, Australia, Hungary
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
AstraZenecaSWOG Clinical Trials Partnerships; Daiichi SankyoRecruitingBreast CancerUnited States, China, Denmark, United Kingdom, Korea, Republic of, Canada, Germany, Italy, Belgium, Spain, Japan, France, Taiwan, Greece, Brazil, Sweden, Puerto Rico
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
Gilead SciencesCompletedBreast CancerUnited States, Canada, Spain, France, Belgium, United Kingdom, Germany
-
Hoffmann-La RocheCompletedTriple Negative Breast CancerUnited States, Korea, Republic of, Belgium, Canada, Germany, United Kingdom, Argentina, Australia, Brazil, Finland, France, Greece, Hungary, Poland, Slovenia, Spain, Taiwan, Turkey, Japan, Singapore, Colombia, Bosnia and Herzegovina, Guatema... and more